Recently, there has been an important move by health organizations to standardize guidelines and rules for the safe administration of subcutaneous biologics. Players in the subcutaneous biologics market are focused on R&D of new products. Market players are also focused on signing agreements with several medical and research establishments for the production of subcutaneous biologics. These agreements have resulted in the development of several new therapies. Subcutaneous Biologics is an ideal product that has multiple applications. It can be used in the treatment of cancer, Alzheimer’s disease, arthritis and Parkinson’s disease. This innovative product has been extensively evaluated and is safe for both men and women of all ages.
Get Free PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
Rising popularity of cosmetic and chronic disease enhances the ever increasing demand for subcutaneous biologics. As a result, the subcutaneous biologics market is expected to witness significant growth in the near future. Revenues are growing in parallel with improvements in diagnostic and therapeutic procedures and products. The ever-improving level of knowledge among the general public about various prevailing medical conditions leads to substantial demand for subcutaneous biologics.
Approval and launch of new products is expected to propel growth of the global subcutaneous biologics market over the forecast period. For instance, in April 2014, F. Hoffmann-La Roche AG received the European Commission approval for its subcutaneous formulation of RoACTEMRA (tocilizumab).
Moreover, high prevalence of chronic diseases is also expected to aid in growth of the global subcutaneous biologics market. For instance, around 50 million people in the U.S. suffered from rheumatoid arthritis, according to The Centers for Disease Control and Prevention. Moreover, the number of cases is expected to increase to 78 million by 2040. T
Major players operating in the global subcutaneous biologics market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2018, the U.S. Food and Drugs Administration accepted biologics license from ‘Genentech’, a member of the Roche Group, for subcutaneous formulation of trastuzumab (Herceptin) for breast cancer treatment.
North America is expected to witness significant growth in the global subcutaneous biologics market, owing to approval and launch of new products. For instance, in September 2018, AstraZenca and Amgen received the U.S. Food and Drug Administration ‘Breakthrough Therapy Designation’ for tezepelumab, which will be used for patients with severe asthma without an eosinophilic phenotype.
Request PDF Brochure with Latest Insights @
Major players operating in the global subcutaneous biologics market focus on approval and launch of new products to expand their product portfolio. For instance, in 2015, Amgen launched Neulasta delivery kit to automate the delivery of drug and preventing infection in cancer patients.
Major players operating in the global subcutaneous biologics market include, AbbVie, Inc., Amgen, Inc., Bristol-Myers Squibb, Biogen Idec, Eisai, Inc., F. Hoffmann-La Roche AG, Genentech Inc., Pfizer Ltd., and Takeda Pharmaceutical Company Ltd.
Market Key Developments:
Major players operating in the global subcutaneous biologics market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2018, the U.S. Food and Drugs Administration approved Roche AG’s Hemlibra for the treatment of adults and children suffering from bleeding episode.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/74
Subcutaneous Biologics Market Segmentation:
By Drug Delivery System
- Prefilled syringes
- Wearable injectors
- Drug reconstitution delivery systems.
- Crohn’s Disease
- Rheumatoid Arthritis
- Breast cancer
Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America [United States, Canada, Mexico]
Middle East & Africa [GCC, North Africa, South Africa]
South America [Brazil, Argentina, Columbia, Chile, Peru].
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Subcutaneous Biologics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Subcutaneous Biologics Industry Impact
Chapter 2 Global Subcutaneous Biologics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Subcutaneous Biologics (Volume and Value) by Type
2.3 Global Subcutaneous Biologics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Subcutaneous Biologics Sales, Consumption, Export, Import by Regions
Chapter 5 North America Subcutaneous Biologics Market Analysis
Chapter 6 East Asia Subcutaneous Biologics Market Analysis
Chapter 7 Europe Subcutaneous Biologics Market Analysis
Chapter 8 South Asia Subcutaneous Biologics Market Analysis
Chapter 9 Southeast Asia Subcutaneous Biologics Market Analysis
Chapter 10 Middle East Subcutaneous Biologics Market Analysis
Chapter 11 Africa Subcutaneous Biologics Market Analysis
Chapter 12 Oceania Subcutaneous Biologics Market Analysis
Chapter 13 South America Subcutaneous Biologics Market Analysis
Chapter 14 Company Profiles and Key Figures in Subcutaneous Biologics Business
Chapter 15 Global Subcutaneous Biologics Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027